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Surface solid dispersion (SSD) of curcumin was developed and characterized with purview to overcome solubility hurdle 
in its pharmacokinetic and pharmacodynamic performance. SSDs were prepared by co-evaporation method using 
polyplasdone XL, croscarmelose sodium, and silicone dioxide and polyethlene glycol 6000 as carrier. The optimized SSD 
(F9) was characterized using FE-SEM and XRD as an analytical tool. The formulation of modified Curcumin shows better 
drug release profile as compared to the natural Curcumin. Formulation F9 released more than 90% of the loaded Curcumin 
within 30 minutes where marketed formulations shows 90% drug only after 60 minutes.   
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INTRODUCTION 
Many of the discovered chemical entities are lipophilic in 
nature and suffer from poor aqueous solubility. Because of 
their low aqueous solubility, dissolution becomes the rate 
limiting step for their systemic absorption and 
bioavailability1, 2. Consequently, the major number of pre-
existing pharmaceutical compounds along with the new 
discovering bioactive compounds suffers from insufficient 
dissolution throughout the gastrointestinal tract and 
therefore achieves inferior systemic exposure after oral 
administration3. There are various generalized approaches 
of solubility enhancement of poorly soluble active 
pharmaceutical ingredients (APIs). Among these, solid 
dispersion is used to be the most popular one and the basic 
technique. Despite it exhibits certain constraints including 
poor miscibility of matrix and drug which is due to their 
different forms of state as crystalline, amorphous or 
molecular causes segregation, use of the water soluble 
polymers causes tackiness or wetness of solid mass of SD, 
amorphous form of the drug produced during solid 
dispersion is less stable and can be converted into the more 
stable crystalline form, commercial limitations include 
laborious and expensive method of its preparation, 
reproducibility, difficulty in formulation, and poor shelf-
life, drug gets entrapped within the polymer structure 
There are systems in which the drug is distributed on the 
surface of a water insoluble carrier to increase solubility 
and dissolution rate such systems are called as surface 
solid dispersions17. Surface solid dispersion may be 
considered as a special type of solid dispersion in which 
the water insoluble drug is weakly bounded onto the 
surface of the water insoluble carrier polymer18. Polymers 
used for surface solid dispersion also have the property of 
fast disintegration in aqueous medium. That is due to their 
hydrophilic nature and extensive swellability in the 
aqueous medium. This exposes the adsorbed drug to the 
medium and then drug is readily dissolute into the 
medium. Curcumin has been reported to have potential 
anti-inflammatory, antibacterial and anti cancerous 
activity. Amongst anti cancerous agent, curcumin has been 
proven efficacious against many cancerous cells. However 
its activity is limited due to low systemic availability after 
per oral administration due to low aqueous solubility.  
Curcumin has been classified as potential BCS class II 
drug therefore it has low solubility and high permeability. 
It is insoluble in aqueous medium and dissolution is the 
rate limiting step for its oral absorption in the body. Drug 
was selected on the basis of its limitation of solubility 
which would be increased by SSD technique. Not only 
this, its low dose also supports this technique as SSD 
allows high ratio of polymers/drug for the formulation. 
Another intent of the study is to fabricate the C-SSD as 
fast disintegrating per oral tablet to facilitate rapid clinical 
effects as an anti-inflammatory and anti cancerous drug. 
 
MATERIALS AND METHODS 
Curcumin was obtained as gift sample from Mankind 
Pharma Ltd. Polyplasdone XL, croscarmelose sodium, 
polyethylene glycol 6000 and silicone dioxide were 
purchased from Wacker Chemie, Geramany. Absolute 
alcohol was obtained from Changshu Yangyuan chemical 
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china; all the solvents used during the study were of HPLC 
grade. 
Preparation of SSD by Co-evaporation method 
Four carriers sodium starch crosscarmelose sodium, 
polyplasdone XL, silicone dioxide and polyethylene 
glycol-6000 in four groups A, B, C and D were used in 
three different drug: carrier ratios (1:1, 1:5, 1:10) hence, 
total twelve formulations were prepared as depicted in 
Table 1 in which the carriers were divided into two broad 
classes, super disintegrates (group A and B) and adsorbent 
(group C and D). For F1 formulation 100 mg of the drug 
was dissolved in 10 ml of ethanol (99.9% v/v) and 100 mg 
of the carrier was dispersed into it as to render drug: carrier 
ratio 1:1. The dispersion was magnetically stirred at 100 
rpm at 70ºC ± 0.5 to completely evaporate the solvent and 
to obtain dry product. The procedure was repeated for 
other formulations with variable amount of carrier in their 
respective ratios. 
 
Evaluation of prepared SSDs  
Equilibrium Solubility study 
Accurately 10 mg of pure drug was added to 25 ml conical 
flask containing 10 ml of distilled water (0.1% w/v) and 
kept for 72 hr at 37˚C ± 0.5 on water bath shaker. Sample 
of 5 ml was withdrawn after 72 hr, filtered through nylon 
filter disc (0.22 μm) and analyzed at 429 nm. Similar study 
was conducted for each formulated SSD (from F1 to F12) 
following same procedure and conditions.  
Drug content determination 
The drug content study was performed taking SSDs 
theoretically equivalent to 10 mg of drug and extracted 
with 5 ml quantity of 99.9% v/v ethanol in two successive 
steps. The solution was filtered through nylon filter disc 
(0.22 μ) and the volume was rendered up to 10ml with 
0.1N HCl buffer pH 1.2. This was diluted 100 times with 
0.1N HCl buffer pH 1.2 and analyzed at 429 nm in 
triplicate and mean value with standard deviation was 
recorded. 
 
In-vitro adsorption study 
Accurately 10 mg of curcumin was added to 100 ml of 
distilled water and ten folds weight (100mg) of 
crosscarmelose sodium was added to it. The mixture was 
magnetically stirred at 100 rpm and temperature was 
maintained at 37˚C ± 0.5 for 4 days. Five milliliters of 
sample was withdrawn at 0, 0.5, 1.0, 2.0, 3.0, 4.0 days and 
analyzed spectrophotometrically at 429 nm to determine 
the percent drug adsorbed with respect to time. This study 
was repeated for polyplasdone XL, silicone dioxide and 
polyethylene glycol-6000. 
 
Characterization studies 
For characterization studies, powder samples of SSD F6, 
F9, silicone dioxide, polyplasdone XL and pure drug were 
subjected to following analysis. 
 
Scanning electron microscopy 
The scanning electron microscopy (SEM) of samples was 
conducted by using scanning electron microscope operated 
at an acceleration voltage of 4 kV. Sample particles were 
coated with a thin gold layer by sputter coater unit (VG 
Microtech, West Sussex, UK) under an argon atmosphere 
in order to make them conductive. The coating time was 5-
6 min and the surface morphology of samples was studied 
by observing the photomicrographs at different 
magnifications ranging between 100 X – 3500 X. 
 
Carrier Class Group Carrier Used Drug : Carrier Ratio 
Super disintegrant 
A Croscarmellose sodium 1:1 1:5 1:10 
B Polyplasdone XL 1:1 1:5 1:10 
Adsorbent 
C Silicone dioxide 1:1 1:5 1:10 
D Polyethylene glycol-6000 1:1 1:5 1:10 
 
X-ray powder diffraction 
X-ray powder diffraction (XRPD) patterns samples of 
were recorded by x-ray diffractometer. The samples were 
irradiated with monochromatized Cu-Kα radiation, 
generated at 1.542 Ǻ wavelength, at 30 kV and 30 mA. 
The samples were scanned over a range of 20º - 100º at the 
chart speed of 10 mm/ 2θ. The intensity of the peaks in 
XPRD patterns was recorded in cps and was studied for 
crystallinity of the samples. 
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RESULTS AND DISCUSSION 
The pure drug curcumin demonstrated solubility of 2.46 
µg/ml in double distilled water that can be consider as a 
close evidence of indicating poor aqueous solubility of 
curcumin. In-vitro adsorption profile of silicone dioxide 
depicted sigmoid curve which is similar to type V 
adsorption isotherms with maximum percent drug 
absorption of 82.75% w/w at 72 hrs. Cross carmelose 
sodium was followed by silicon dioxide with 61.68% w/w 
drug absorption in multilayer as generated curve with 
multiple inflections, analogous to the type IV isotherm and 
both became constant after 72 hr. Polyplasdone XL and 
Polyethylene glycol 6000 adsorbed curcumin to a 
maximum of 24.07% w/w and 21.88% w/w respectively. 
In vitro absorption profiles of these two became constant at 
24 hr after the single inflection, indicating monolayeric 
adsorption of curcumin.  
 
Fig. 1  In-vitro adsorption profile of drug on various carriers 
 
Fig. 2 DRS spectra of pure drug (A), Drug/polyplasdone XL (B), Drug/silicone dioxide (C) drug/croscarmelose 
sodium (D) and drug/polyethylene glycol 6000 (E) 
 
SSD is a drug: carrier dispersion where drug is deposited 
over carrier and carriers employed for SSD possess 
hydrophilic character, high aqueous dispersability and 
large specific surface area. Based on the literature value of 
specific surface area the carriers can be arranged in the 
increasing order (Polyethylene glycol 6000 < polyplasdone 
XL < croscarmelose sodium < silicone dioxide) and extent 
of in-vitro adsorption are expected to be in same order. 
The results complied with theory except for Polyethylene 
glycol 6000 and polyplasdone XL, where polyethylene 
glycol 6000 and polyplasdone XL showed low adsorption 
that attributed to its chemical structural (which is further 
explained in details) and rendered the drug more soluble in 
the media in spite of its absorption. Rest of the carriers 
were uniformly dispersed in the test media and provided 
site for absorption related to their specific surface area. 
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Consequently, the order of adsorption was Polyethylene 
glycol 6000 < Polyplasdone XL < croscarmelose sodium < 
silicone di-oxide but this did not imply the release order. 
Consequently, SSDs were formulated using various drug-
carrier ratios (by a factor of 5) and assessed for solubility 
enhancement and in-vitro release characteristics. 
The identification of compatibility of drug with excipients 
is one of the primary requisite when designing a dosage 
form. Since excipients comprise a major portion of dosage 
form, the possibility for drug excipients interaction that 
may affect drug stability, dissolution rate and consequently 
drug adsorption exists. The stored binary samples were 
analyzed by DRS. The spectral analysis of curcumin (Fig. 
2A) showed characteristic bands at wave number 3634, 
2885, 2362, 1626, 1594, 1423, 1368, 1232, 1179, 1025 
corresponding to O-H stretching, C=O  stretching, C=C 
stretching, Ar-H stretching, C-H deformation, CH3  
deformation, O-H bending, C-O stretching, Ar-H (o,m). 
These characteristic stretching vibrations were documented 
in blends: Drug/polyplasdone XL, Drug/silicone dioxide 
drug/croscarmelose sodium and drug/polyethylene glycol 
6000 (Fig 2 B-E) without any petite shift in the wave 
number of the peaks, however slight changes in intensity 
of the peaks was due to decreased concentration OD drug 
in the blend. Slight changes in intensity of the peaks within 
acceptable limits indicated absence of interaction between 
drug and excipients used to prepare surface solid 
dispersion. 
 
Fig.5 : SEM micrographs of Drug (A), polyplasdone XL(B), SSD F6 (C) , silicone dioxide (D), SSD F9 (E) at 500X 
magnification. 
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Relative to pure drug, SSDs displayed better solubility 
enhancements. Solubility of silicone dioxide and 
polyplasdone XL was enhanced with increasing drug: 
carrier ratios as 1:1<1:5<1:10. On the contrary 
croscarmelose sodium showed solubility enhancement 
in the order 1:1<1:5>1:10. In this study croscarmelose 
sodium displayed enhanced drug solubility at 
drug:carrier concentration of 1:5 which might be 
attributed to the gel forming ability of croscarmelose 
sodium. The drug must first diffuse through gel layer 
before being released into medium. Polyplasdone XL 
swells rapidly without gel formation because of high 
cross linking density and increased drug solubility at 
higher drug:polymer ratio i.e 1:10.  
Analytically, carriers can be classified into swellable 
and non-swellable adsorbent groups. Swellable carriers, 
croscarmelose sodium and polyplasdone XL are 
reported to increase the solubility of poorly soluble 
drugs. Possible mechanism for increasing drug solubility 
is better being explained on the basis of their chemical 
structures. Polyplasdone XL is insoluble synthetically 
crosslinked homopolymer of N-vinyl-2-pyrrolidone. 
These repeating units in Polyplasdone XL are 
responsible for the crystallization inhibition due to its 
anti plasticizing effect and often produce efficient steric 
hindrance for nucleation and crystal growth. 
Chemically, these units are similar to N-
methylpyrrolidone (NMP), which is water miscible, 
aprotic polar solvent with high interfacial activity used 
as solubilising agent .Thus, polyplasdone XL with 
porous and granular particles that generates high 
specific surface area combined with unique solvent-like 
chemistry results in high interfacial activity that serves 
to enhance the solubility of hydrophobic drugs.  
In contrast, croscarmelose sodium is the sodium salt of 
cross-linked carboxymethyl ether of starch and its 
backbone is composed mostly of glucose repeat units. 
Hydrophilic carboxymethyl groups disturb hydrogen 
bonding within polymer but many free hydroxyl groups 
of glucose residue present on the polymer surface are 
reportedly responsible to enhance the solubility of 
hydrophobic drugs. Hydrophilic surface interacts with 
water molecules after their rapid intake from aqueous 
medium and increase the water molecule interactions on 
its surface microenvironments. In this way, hydrophilic 
carriers increase wetting and reduce interfacial tension 
between hydrophobic drug and water. According to the 
literature, particles are spherical and non porous that 
form gel on complete hydration.  
Non swellable, adsorbent carriers, aerosil and 
polyethylene glycol 6000 insoluble with highly porous 
nature which provides high specific surface area. 
According to the literature, pores of the adsorbent 
restrict the nucleation during re-crystallization of drug 
and as mentioned in adsorption results, a large amount 
of curcumin was homogeneously distributed in a mono-
layer on adsorbents. In the case of a monolayer no work 
is needed to break the bonds between drug molecules, as 
reported by which results in higher apparent solubility 
of the drug. Apart from this, surface adsorption for 
water by silicone dioxide was reportedly attributed to 
high silicone dioxide group (Si-O2) density on the 
surface which is responsible for similar mechanism of 
drug wetting and enhancing its solubility. 
Polyethylene glycol 1000 considered here to analyze the 
role of adsorption property on the solubility 
enhancement without a hydrophilic surface and results 
showed no prominent solubility enhancements with 
carrier’s hydrophobic surface. Due to its hydrophobic 
surface, polyethylene glycol 6000 adsorbed the drug 
strongly and consequently did not release it readily. 
That proved, for increasing wet ability of drug, carrier 
with hydrophilic surface is required which also possess 
good adsorption characteristics and aerosil fitted in this 
domain 
The SEM photomicrograph (Fig. 2A) of pure drug 
revealed irregular crystals with plain surfaces. The SEM 
images of polyplasdone XL-10 (Fig. 2B) depicted flaky 
non uniform sized amorphous particles. The SEM 
micrograph of silicone dioxide (Fig. 2D) displayed 
round edged non uniform sized amorphous particles. 
The amorphous surface probably played an important 
role in providing larger surface area for drug 
deposition9. Porous and amorphous surface allowed the 
deep penetration and restricted the drug re-
crystallization during the processing of SSD10 SEM 
image of Fig. 2E revealed deposition of very fine 
microcrystals of curcumin on the silicon dioxide 
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particles which rendered roughness to the smooth 
surfaces of aerosil and was indicative of SSD formation. 
The deposition led to major crystal destruction marked 
by faint evidence of drug crystals further proved by the 
XRPD results. 
Diffraction pattern of curcumin was co-relatable with 
SEM images. The pure drug was highly crystalline as 
X-rays diffracted at sharp angles from well defined 
crystalline surface. Generation of halo areas in the 
silicone dioxide and SSD spectra was due to amorphous 
surface of aerosil and amorphization of crystalline drug 
in SSD, as X-rays were diffracted from the irregular and 
rough surface of SSD Drug crystallinity calculation 
provided a quantitative revelation about the reduction in 
crystallinity after SSD formation as amorphization led 
to solubility enhancement in comparison to pure 
crystalline drug 
 
CONCLUSION 
The optimize formulation displayed highest solubility of 
35.11+- 0.34 micro gram/ml in double distilled water 
silicon dioxide in 1: 10 ratio with the drug resulted in 
maximum % cumulative drug release (% CDR)  of 
93.46 % which was due to fine agreement of the 
solubility study as improve drug dissolution was a result 
of increased solubility. 
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